======= GALNT2 =======
== Gene Information ==
* **Official Symbol**: GALNT2
* **Official Name**: polypeptide N-acetylgalactosaminyltransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2590|2590]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q10471|Q10471]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GALNT2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALNT2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602274|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. The encoded protein may be involved in O-linked glycosylation of the immunoglobulin A1 hinge region. This gene may influence triglyceride levels, and may be involved Type 2 diabetes, as well as several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014].
* **UniProt Summary**: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Has a broad spectrum of substrates for peptides such as EA2, Muc5AC, Muc1a, Muc1b. Probably involved in O-linked glycosylation of the immunoglobulin A1 (IgA1) hinge region. {ECO:0000269|PubMed:12438318, ECO:0000269|PubMed:16434399, ECO:0000269|PubMed:7592619, ECO:0000269|PubMed:9295285}.
|Ricin B lectin|
|Glycos transf 2|
|immunoglobulin biosynthetic process|
|protein O-linked glycosylation via threonine|
|protein O-linked glycosylation via serine|
|polypeptide N-acetylgalactosaminyltransferase activity|
|Golgi stack|
|O-glycan processing|
|manganese ion binding|
|integral component of Golgi membrane|
|peptidyl-threonine modification|
|Golgi cisterna membrane|
|protein O-linked glycosylation|
|immunoglobulin production|
|carbohydrate binding|
|production of molecular mediator of immune response|
|peptidyl-serine modification|
|macromolecule glycosylation|
|protein glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|glycoprotein metabolic process|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|perinuclear region of cytoplasm|
|peptidyl-amino acid modification|
|endoplasmic reticulum membrane|
|Golgi apparatus|
|carbohydrate derivative metabolic process|
|organonitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|extracellular region|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.17|
|[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.82|
|[[:results:exp219|A-395N 10μM R05 exp219]]|1.71|
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.79|
|[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.01|
|[[:results:exp122|Golgicide-A 4μM R03 exp122]]|3.84|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9996
* **Expression level (log2 read counts)**: 9.32
{{:chemogenomics:nalm6 dist.png?nolink |}}